Yttrium-90 radioisotopes produced at the University of Missouri Research Reactor are extending and improving the lives of patients with liver cancer.

March 28, 2024

Liver cancer is one of the deadliest forms of the disease, and the American Cancer Society estimates a 71 percent mortality rate for patients in the U.S. diagnosed with primary liver and intrahepatic bile duct cancer.